Specifically, the non-competitive inhibition of MMP2, MMP14 and MMP13 using potassium ferricyanide has shown in some studies significant reductions in tumor growth in a murine model of breast cancer lung metastases with VCO growth. This evidence concerns the gene MMP2 and neoplasm.